ClinicalTrials.gg
Sign In
Not yet recruitingNCT07825532FIBMASCUpdated Sep 17, 2026

Comparison of Induced Membrane Technique With Vascularized Fibula Flap for Pediatric Limb Reconstruction

An observational study in Bone Loss, Microsurgery and Reconstruction, sponsored by Central Hospital, Nancy, France. Not yet recruiting. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Central Hospital, Nancy, France · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
140
Ages
0 Years to 18 Years
Sex
All
01

Study summary

This study has for goal to evaluate vascularised fibula flap and induced membrane for children's bone loss.

02

Conditions studied

  • Bone Loss
  • Microsurgery
  • Reconstruction
  • Children
  • Induced Membrane
  • Fibula Flap
03

In context

Bone Diseases, Metabolic

661 studies on the registry are indexed under Bone Diseases, Metabolic; 93 are open to participants now.

This study's planned enrollment of 140 is above the median of 80 across 138 observational studies indexed under Bone Diseases, Metabolic.

Browse Bone Diseases, Metabolic studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.

Browse Central Hospital, Nancy, France studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Children from 0 to 18 years.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient under 18 years old
  • Procedure by induced membrane or vascularised fibula flap for limb reconstruction from 2000 to 2026

Exclusion criteria

Exclusion Criteria:

  • Patient under 6 months follow up
  • Patient who underwent vascularised fibula flap with epiphysis
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
140 participants (estimated)
Patient registry
No

Interventions

  • Procedurelimb reconstruction

    * induced membrane * vascularised fibula

06

What researchers measure

Primary outcomes

  1. Complete consolidation at 12 months

    The measures will be evaluated on x-rays. Consolidation is considerred achieved when at least 3 out of 4 cortices are fused. Xrays are done on every consultations

    Time frame: assessment of consolidation 12 months after surgical reconstruction, for induced membrane group the first time of surgery is considerred

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Oct 2026, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 5, 2026
First posted
Sep 17, 2026
StartEst.
Sep 15, 2026
Primary completionEst.
Oct 1, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07825532
Lead sponsor
Central Hospital, Nancy, France
Responsible party
PIESSAT Colin (Orthopedic surgeon, Central Hospital, Nancy, France) — Principal investigator
First posted
Sep 17, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 17, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Bone Diseases, Metabolic →

Other studies from this sponsor

Central Hospital, Nancy, France →

Start the discussion